174 related articles for article (PubMed ID: 34532092)
1. Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients.
Wang Y; Xiong F; Yang J; Xia T; Jia Z; Shen J; Xu C; Feng J; Lu Y
J Gastrointest Oncol; 2021 Aug; 12(4):1338-1350. PubMed ID: 34532092
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non-small cell lung cancer after surgery.
Zhang L; Zhang H; Yue D; Wei W; Chen Y; Zhao X; Zhu J; Zhang B; Zhang Z; Wang C
Thorac Cancer; 2019 Jul; 10(7):1581-1589. PubMed ID: 31161711
[TBL] [Abstract][Full Text] [Related]
3. Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies.
Cai X; Chen Z; Chen J; Ma X; Bai M; Wang T; Chen X; Wu D; Wei L; Li X; Lin Q; Wen J; Ruan D; Lin Z; Dong M; Wu X
J Cancer; 2018; 9(1):189-197. PubMed ID: 29290785
[No Abstract] [Full Text] [Related]
4. The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy.
Chen ZH; Zhang XP; Cai XR; Xie SD; Liu MM; Lin JX; Ma XK; Chen J; Lin Q; Dong M; Wu XY; Wen JY; Xu RH
J Cancer; 2018; 9(19):3467-3478. PubMed ID: 30310503
[No Abstract] [Full Text] [Related]
5. The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer.
Zhang C; Li Y; Ji R; Zhang W; Zhang C; Dan Y; Qian H; He A
Onco Targets Ther; 2019; 12():9559-9568. PubMed ID: 32009792
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio on Survival Outcome for Patients With Locally Advanced Oral Squamous Cell Carcinoma.
Tsai MH; Chuang HC; Lin YT; Yang KL; Lu H; Huang TL; Tsai WL; Su YY; Fang FM
Technol Cancer Res Treat; 2022; 21():15330338221141254. PubMed ID: 36426570
[No Abstract] [Full Text] [Related]
7. Pretreatment serum albumin-to-alkaline phosphatase ratio is an independent prognosticator of survival in patients with metastatic gastric cancer.
Li YT; Zhou XS; Han XM; Tian J; Qin Y; Zhang T; Liu JL
World J Gastrointest Oncol; 2022 May; 14(5):1002-1013. PubMed ID: 35646278
[TBL] [Abstract][Full Text] [Related]
8. Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepatocellular and Cholangiocarcinoma.
Zhang F; Lu S; Tian M; Hu K; Chen R; Zhang B; Ren Z; Shi Y; Yin X
J Cancer; 2020; 11(17):5177-5186. PubMed ID: 32742464
[No Abstract] [Full Text] [Related]
9. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database.
Li SJ; Lv WY; Du H; Li YJ; Zhang WB; Che GW; Liu LX
Int J Surg; 2019 Sep; 69():32-42. PubMed ID: 31319230
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of pretreatment albumin-to-alkaline phosphatase ratio in locally advanced laryngeal and hypopharyngeal cancer: Retrospective cohort study.
Wu J; You K; Jiang Y; Shen T; Song J; Chen C; Liu Y
J Cancer; 2021; 12(20):6182-6188. PubMed ID: 34539891
[No Abstract] [Full Text] [Related]
11. Prognostic impact of the pretreatment albumin to alkaline phosphatase ratio for nonmetastatic breast cancer patients.
Long ZQ; Hua X; Zhang WW; Lv SW; Deng JP; Guo L; He ZY; Lin HX
Cancer Manag Res; 2019; 11():4809-4814. PubMed ID: 31213902
[No Abstract] [Full Text] [Related]
12. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
[TBL] [Abstract][Full Text] [Related]
13. The impact of serum albumin-to-alkaline phosphatase ratio in cervical cancer patients treated with definitive chemoradiotherapy.
Onal C; Gultekin M; Yavas G; Oymak E; Yuce Sari S; Guler OC; Yigit E; Yildiz F
J Obstet Gynaecol; 2022 Aug; 42(6):2426-2432. PubMed ID: 35653776
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio for
Gan Y; Ren J; Xian J; Yu H; Jin J; Li D; Li W
Int J Gen Med; 2022; 15():3405-3416. PubMed ID: 35378914
[TBL] [Abstract][Full Text] [Related]
15. Albumin-to-alkaline phosphatase ratio: A novel prognostic index for patients with driver mutation-negative advanced non-small cell lung cancer.
Liu X; Li Y; Zhao Q; Jiang H; Ni J; Cai H
Clin Respir J; 2021 May; 15(5):540-549. PubMed ID: 33565707
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of combined pre- and postoperative albumin-to-alkaline phosphatase ratio for patients with hepatocellular carcinoma undergoing trans-catheter chemoembolisation.
Li J; Yang S; Li C; Zhu G; Xia J
Clin Radiol; 2023 Apr; 78(4):301-309. PubMed ID: 36690510
[TBL] [Abstract][Full Text] [Related]
17. Albumin-To-Alkaline Phosphatase Ratio as a Novel and Promising Prognostic Biomarker in Patients Undergoing Esophagectomy for Carcinoma: A Propensity Score Matching Study.
Zhu X; Chen D; Li S; Zhang W; Li Y; Wang X; Zhou J; Wen Z
Front Oncol; 2021; 11():764076. PubMed ID: 34746006
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram prediction model based on albumin-to-alkaline phosphatase ratio for predicting the prognosis of gallbladder carcinoma.
Fan Z; Liu B; Shang P
Pathol Oncol Res; 2022; 28():1610818. PubMed ID: 36685104
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of a Nomogram Based on the Dynamic Albumin-to-Alkaline Phosphatase Ratio for Patients with Extensive-Stage Small-Cell Lung Cancer.
Li B; Jiang C; Wang R; Zou B; Xie P; Li W; Sun X; Yu J; Wang L
Onco Targets Ther; 2020; 13():9043-9057. PubMed ID: 32982294
[TBL] [Abstract][Full Text] [Related]
20. The preoperative platelet distribution width: A predictive factor of the prognosis in patients with non-small cell lung cancer.
Liu C; Zhang H; Qi Q; Zhang B; Yue D; Wang C
Thorac Cancer; 2020 Apr; 11(4):918-927. PubMed ID: 32061027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]